Cargando…
Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study
OBJECTIVES: Up to 50% of heart failure (HF) patients may be frail and have worse clinical outcomes than non-frail patients. The benefits of HF-specific pharmacotherapy (beta-blockers, ACE-inhibitors/angiotensin-receptor-blockers and mineralocorticoid-receptor-antagonist) in this population are uncle...
Autores principales: | Sharma, Yogesh, Horwood, Chris, Hakendorf, Paul, Thompson, Campbell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486223/ https://www.ncbi.nlm.nih.gov/pubmed/36123054 http://dx.doi.org/10.1136/bmjopen-2021-059905 |
Ejemplares similares
-
Trends in Frailty and Use of Evidence-Based Pharmacotherapy for Heart Failure in Australian Hospitalised Patients: An Observational Study
por: Sharma, Yogesh, et al.
Publicado: (2021) -
Prevalence of Hypovitaminosis C and its Relationship with Frailty in Older Hospitalised Patients: A Cross-Sectional Study
por: Sharma, Yogesh, et al.
Publicado: (2021) -
Relationship between Vitamin C Deficiency and Cognitive Impairment in Older Hospitalised Patients: A Cross-Sectional Study
por: Sharma, Yogesh, et al.
Publicado: (2022) -
Clinical characteristics and outcomes of influenza A and B virus infection in adult Australian hospitalised patients
por: Sharma, Yogesh, et al.
Publicado: (2020) -
External Validation of the Hospital Frailty-Risk Score in Predicting Clinical Outcomes in Older Heart-Failure Patients in Australia
por: Sharma, Yogesh, et al.
Publicado: (2022)